Obtain Trial

Obtain technology trial within target health systems

Innovations need to be championed within health systems to secure prioritization for trialing.

Trials must be carefully designed to ensure that data on value-driving endpoints are captured, to inform the case for long term adoption.

Assess uses economic models to identify which additional evidence can be expected to have the largest impact on the probability of securing long term adoption.

Learn more
team
Photo by Julia Koblitz on Unsplash
How We Do It

Analytic approach to informing technology trial decisions

Analyses support innovators to articulate the Trial Case for new technology in development. A global network of experts bring methods and insights from health technology assessment and economic modelling to help innovative companies demonstrate that their technologies should be prioritized for trial, and to ensure trials collect evidence to inform procurement decision-making.

Problem sizing in target healthcare system

Current challenges in achieving optimal outcomes in standard care can be both characterized and quantified.

  1. Problem Size: Limitations in current care leading to sub-optimal clinical and cost outcomes
  2. Root Cause: Key drivers of limitations observed in current care
  3. Technology Impact: The extent to which the new technology can be expected to influence outcomes

The analysis describes and quantifies the extent to which new technology can be expected to influence different outcomes, supporting innovators to demonstrate value in technology trial.

team
Photo by camilo jimenez on Unsplash
team

Implementation trial design

Technology implementation into health systems intended to generate evidence of its value to inform adoption decisions must include economic endpoints of priority importance to decision-makers.

Implementation trial design considers:

  • Economic endpoints of importance to payers
  • Data collection for parameters of greatest uncertainty
Testimonials

What our clients say

Careteam

“We are extremely satisfied with the work done and have already recommended the service to others.

This program has been invaluable to us, I can't say enough to recommend it - this kind of evidence is vital to digital health sales and incredibly hard to find. We plan to include the service in major research projects in the future to demonstrate the economic impact of our interventions.”

Rob Attwell
COO
Tenomix

“The economic evaluation that was conducted helped with initial conversations with our investors and it ultimately led to the closure of our first financing round.

The model conducted by the ASSESS team also really gave my team and I a great starting point to truly understand the complete economics behind the problem we are solving and what types of clinical studies that we need to build in order to demonstrate the economic value proposition of the technology.”

Saumik Biswas
CEO, Founder
CarePal

“The economic modeling report is a foundational tool that supports our firm’s growth by providing data-driven insights for investors, internal decision-makers, and potential clients. I am highly satisfied and would recommend the service to other firms.”

Cindy Sim
CEO
Greenspace

“Our team was very happy with the level of thoroughness and rigor of the work and deliverables from the ASSESS team, as well as their communication. We would recommend the service to other organizations given the ease of working with the ASSESS team and the rigor of their work.”

Tanya Scarapicchia

Contact Us

Contact us to learn more about how insights from The ASSESS Project can help your organization to obtain technology trial in target health systems, and structure a trial appropriately to inform adoption decision-making.

Let's talk